## Abstract Aberrant epigenetic regulation of gene expression contributes to tumor initiation and progression. Studies from a plethora of hematologic and solid tumors support the use of histone deacetylase inhibitors (HDACi) as potent anticancer agents. The mechanism(s) of HDACiβinduced cancer grow
Telomerase as a possible target for anticancer therapy
β Scribed by Chantal Autexier
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 68 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1074-5521
No coin nor oath required. For personal study only.
β¦ Synopsis
Telomeres, the termini of chromosomes, provide essential stability to linear eukaryotic chromosomes. The enzyme telomerase is one mechanism that maintains telomeres, and is activated in 85% of human cancer cells. New studies on peptide nucleic acids (PNAs) that inhibit telomerase have demonstrated that unexpected regions of the enzyme can serve as targets for inhibitors. The novel delivery method used expands the utility of PNAs.
π SIMILAR VOLUMES
The currently understood function for Ras in signal transduction is in mediating the transmission of signals from external growth factors to the cell nucleus. Mutated forms of this GTP-binding protein are found in 30% of human cancers with particularly high prevalence in colon and pancreatic carcino
## Abstract ## Background Metastatic properties of tumors involve movement of cancerous cells from one place to another and tissue invasion. Metastatic cells have altered cell adhesion and movement that can be examined by __in vitro__ chemotaxis assays. The Rho/ROCK/LIM kinase pathway is one of th